Immediate Impact

56 standout
Sub-graph 1 of 24

Citing Papers

Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations
2024 Standout
Targeted protein degradation: from mechanisms to clinic
2024 Standout
4 intermediate papers

Works of Amy K. O’Sullivan being referenced

Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study
2012
Cost Estimation of Cardiovascular Disease Events in the US
2011

Author Peers

Author Last Decade Papers Cites
Amy K. O’Sullivan 202 125 184 154 43 843
Jonathan R. Korn 115 138 99 42 37 834
Roy Nitulescu 254 152 118 39 29 768
Sofia Pedro 112 51 88 56 36 911
Ashley Buchanan 36 81 212 186 49 961
Jonas Christoffer Lindstrøm 83 104 128 101 52 896
Bo Nancy Yu 117 55 233 109 26 962
Carolyn Harley 138 178 124 19 33 948
Kavita Sail 50 61 228 223 38 893
Yoojin Lee 173 42 89 61 41 938
Leticia León 62 42 58 124 71 961

All Works

Loading papers...

Rankless by CCL
2026